White Square Capital, a hedge fund that bet GameStop stock would go down in January, has been forced to close down. According to The Financial Times, the London-based hedge fund experienced double-digit percent losses from its attempts to “naked short” the U.S. video game store chain. Simply put, it placed positions that would make money...
Category: TRENDS EYE VIEW
CHINA BUSINESS ESPIONAGE NETS $500 BILLION A YEAR
Talk about an imbalance in trade. China’s net from theft of intellectual property and trade secrets from U.S. companies amounts to a half trillion in value a year. That’s according to William Evanina, the recently retired chief of the U.S. National Counterintelligence and Security Center. In 2020, the total U.S. trade deficit with China was...
CHINA SENDS PIC OF DONG
A picture is worth a thousand words…unless it provokes a thousand questions. That’s not exactly a proverb, but it does sum up China’s odd response to rumors that one of its top security officials, Dong Jingwei had defected to the U.S. this past March. The story, based on several unnamed government sources, was first reported...
TRUDEAU MOVES TO REGULATE DIGITAL MEDIA
The Canadian government has, for decades, required TV and radio broadcasters to produce and distribute local content, as a way of preserving Canada’s own culture and limiting the influence of U.S. culture which permeates so much of the media that Canadians consume. That influence is seen as a powerful “cultural invasion…that can steamroll any culture...
FDA & BIG PHARMA, ONE BIG CLUB
The Trends Journal has published several articles recently dealing with the U.S. Food and Drug Administration’s approval of an Alzheimer’s drug, aducanumab, produced by Biogen and sold as Aduhelm, the first new drug for Alzheimer’s disease in almost twenty years. Those articles, such as 15 June’s “ALZHEIMER’S DRUG? FORGET ABOUT IT” and another in this...
FDA APPROVES NON-EVIDENCE BASED DRUG
In our 15 June 2021 article, “ALZHEIMER’S DRUG? FORGET ABOUT IT,” Trends Journal reported on the dissent voiced over the FDA’s approval of Biogen’s new Alzheimer’s drug, the first new Alzheimer’s drug in almost 20 years, aducanumab, to be sold as Aduhelm. The dissent focused on the lack of clinical evidence of the drug’s benefit....
U.S. INTEREST, TRUST IN MEDIA ON THE WANE
The results of a survey on media consumption around the world show that the country where the level of trust between news providers and consumers is lowest is the U.S. RT.com reported on 24 June on the study, Digital News Report 2021, conducted by Oxford University and the Reuters Institute for the Study of Journalism....
MELATONIN AND METHYL B12 ON FDA HIT LIST?
People who use currently common supplements to help with sleep and other issues may be in for a rude awakening. The FDA is targeting melatonin, choline chloride, oxitriptan (also known as 5-hydroxytryptophan or 5-HTP) and methylcobalamin (or methyl B12) for tighter regulation, or even possible bans. An online meeting scheduled on June 9 of the...
TAX EVADING BLOOMBERG TELLS AMERICANS TO GIVE UP HOME OWNING DREAMS
Bloomberg featured an opinion piece entitled “America Should Become A Nation of Renters” last week. It argued that mega-corporate landlord firms swallowing up single family homes across the country should actually be seen as a good thing. Nevermind that for most owners, their home serves purposes more important than investment. Their homes are (1) shelter,...
CHINA CRUSHES NEWSPAPER’S DISSENT IN NAME OF “SECURITY”
China is again blazing the dystopian path for the rest of the world to follow. 500 Chinese police swarmed the offices of Apple Daily, a pro-democracy Hong Kong newspaper, on Thursday. In addition to shutting down operations of the news organization and freezing their assets, along with several connected companies, police conducted raids on four...